Sign in Subscribe
Cardiology

New Contrast Agent for MRI May Aid in Diagnosing Vascular Diseases

Strategic Insights

— 1 min read

Researchers from Japan have developed a new class of dye-based magnetic resonance imaging (MRI) contrast agents that may be useful in diagnosing vascular diseases. According to a study published in Bioorganic & Medicinal Chemistry Letters, the new contrast agent, EB-DTPA-Gd, accumulates at the site of endothelial injury, allowing for successful in vivo MR detection of vascular endothelial injury. This indicates the agent's potential for diagnosing vascular diseases.

Key Takeaways:

  • The new contrast agent, EB-DTPA-Gd, was designed and synthesized for use with MRI to diagnose vascular diseases.
  • The agent accumulates at the site of endothelial injury, allowing for successful in vivo MR detection of vascular endothelial injury.
  • The study was conducted using isolated porcine blood vessels and an ex vivo experiment using rat, with in vivo MR detection also successful in rat with a common carotid artery injured by balloon treatment.
  • The researchers concluded that the EB-DTPA-Gd is potentially useful for the diagnosis of vascular diseases.
  • The study provides evidence of the agent's potential for use in diagnosing vascular diseases.
  • Kyushu University's Engineering Faculty and the Department of Applied Chemistry are mentioned as the research institutions involved in the study.
  • Y. Katayama, from the Kyushu University, Engineering Faculty, Department of Applied Chemistry, is listed as a contact person for additional information.
  • Pergamon-Elsevier Science Ltd. is mentioned as the publisher of the journal Bioorganic & Medicinal Chemistry Letters.

Statistics:

  • The study was published in Bioorganic & Medicinal Chemistry Letters, volume 14, issue 11, in 2004.
  • The article was prepared by Heart Disease Weekly editors from staff and other reports.
  • The publication date of the study was not mentioned in the source, but dates back to 2004.
  • The study highlights the potential of MRI contrast agents in diagnosing vascular diseases.

Sources:

  • Yamamoto, T., et al. (2004). In vivo MR detection of vascular endothelial injury using a new class of MRI contrast agent. Bioorg Med Chem Lett, 14(11), 2787-2790.
  • Katayama, Y. (Contact person for additional information)
  • Pergamon-Elsevier Science Ltd. (Publisher)
  • Heart Disease Weekly (Original source for prepared article)

Read more